However, recent studies demonstrated that lower levels of serum and mesenteric adiponectin in active CD patients clearly suggest a defective regulation of that anti-inflammatory adipokine’s pathway in the pathogenesis of CD [53]. The gene discussed is ADIPOQ; the disease is Cowden disease.